News

Tue, 07/01/2025

Research from the University of Kansas suppresses coronavirus by targeting Mac1

A new study published in mBio details the vulnerability of coronaviruses to inhibitors of a small protein domain called Mac1, or the “macrodomain,” found in all coronaviruses such as SARS-CoV-2 and MERS-CoV.
Fri, 05/23/2025

Bloom, CBID graduate, promoted to Associate Professor with tenure.

Chancellor Douglas A. Girod has approved the promotion and award of tenure, where indicated, for 44 individuals at the University of Kansas Lawrence and Edwards campuses and 114 individuals at the KU Medical Center campus.
Thu, 03/27/2025

Tunge Named AAAS fellow

“These four researchers have demonstrated excellence in their fields and have done so in a way that reflects well on our entire university. As one of the nation’s leading research institutions, KU strives to make discoveries that change the world — and these four scholars are helping us fulfill that mission every day," said Chancellor Douglas A. Girod.
Fri, 03/07/2025

Experts in language promotion, structural biology and extinction receive KU Research Achievement Awards

The annual awards recognize outstanding unclassified academic staff, unclassified professional staff and postdoctoral fellows whose research significantly influenced their fields and expanded intellectual or societal insights.
Fri, 02/28/2025

Hutchison earns new water reservoir safety grant

Dr. Justin Hutchison, Dept. of Civil, Environmental, & Architectural Engineering, was awarded $620,001 by the Kansas Water Resources Institute.
Mon, 02/24/2025

KU students to present at Kansas Undergraduate Research Day at the Capitol

Undergraduate researchers from the University of Kansas Lawrence and Medical Center campuses will present their research projects Feb. 26 as part of Kansas Undergraduate Research Day at the Capitol.
Fri, 01/31/2025

Chandler earns $2,163,077 from National Institutes of Health

Former CBID project leader Dr. Josephine Chandler, Department of Molecular Biosciences, has been awarded an NIH grant for $2,162,077. Her project is titled "Quorum sensing evolution and function in mixed bacterial communities."
Fri, 01/31/2025

Sathyamoorthi builds collaboration with Unio Biotech LLC

CBID graduate Dr. Shyam Sathyamoorthi, Department of Medicinal Chemistry, has been awarded $229,300 for a collaboration with Unio Biotech LLC.
Fri, 01/31/2025

Tony Fehr chosen for prestigious early-career presidential award

Two KU professors — Anthony Fehr, associate professor of molecular biosciences, and Gibum Kwon, associate professor of mechanical engineering — were recently chosen for the PECASE Award, the highest honor given by the U.S. government to early-career researchers who show great potential for leading scientific advancements in the 21st century.
Tue, 12/31/2024

Orozco wins New Faculty Research Development Award

CBID graduate Dr. Robin Orozco, Department of Molecular Biosciences, wins a New Faculty Research Development Award ($5,000) for her project titled "Understanding the Benefits of the Commonly Expressed, Disease-causing Mutation of PTPN22."
Fri, 12/20/2024

Wang lab research points the way to lifesaving antiparasitic drugs while unlocking a scientific mystery

A breakthrough in understanding how a single-cell parasite makes ergosterol (its version of cholesterol) could lead to more effective drugs for human leishmaniasis, a parasitic disease that inflicts about 1 million people and kills about 30,000 people around the world every year.
Tue, 11/26/2024

Hefty lab partners with Biotech Lab producing vaccines for Lyme disease and Chlamydia

The University of Kansas is helping to develop both a Lyme disease vaccine and a Chlamydia vaccine with Lawrence born biotechnology lab, Design-Zyme, and the projects all started with help from a KU graduate student. Peter Petillo, Design-Zyme founder and CEO, and Professor Scott Hefty, from the KU school of molecular biosciences, act as the foundation for a partnership between university and industry.
Thu, 10/17/2024

Design-Zyme, KU collaboration results in $3 million SBIR award for Lyme disease vaccine development

The woods can be a place of adventure and beauty, a peaceful escape for a walk. But among the leaves and grass, the threat of ticks can turn a hike into a health-altering encounter with Lyme disease. A recent $3 million Small Business Innovation Research award will fund the research and development of a vaccine to stop Lyme disease in its tracks.
Thu, 10/03/2024

Professor Jon Tunge named August 2024 Walter and Roy Cross Professional Service Award recipient

The Department of Chemistry congratulates Professor Jon Tunge on receiving the August 2024 Walter and Roy Cross Professional Service Award!
Mon, 09/30/2024

Kim, CBID research project leader, awarded $25,000

Hyunjoon Kim, CBID research project leader and Assistant Professor of Pharmaceutical Chemistry, was awarded $25,000 by University of Kansas Medical Center Research Institute to study "Novel TLR7/8 agonists for bladder cancer immunotherapy".
Mon, 09/30/2024

Sathyamoorthi, CBID research graduate, granted $76,500

Shyam Sathyamoorthi, Associate Professor of Medicinal Chemistry and CBID research project leader graduate, won a new award from Kansas State University. This award will provide $76,500 to study "Illuminating Dark Antibiotics: A Novel Synthesis of Streptothricin F and First Total Synthesis of BD-12 and Albothricin".
Mon, 09/16/2024

Zückert awarded Chancellors Club Teaching Professorship

Former CBID pilot project leader Wolfram Zückert awarded Chancellors Club Teaching Professorship at The University of Kansas Medical Center.
Mon, 09/09/2024

CBID pilot leader Baral's discovery could help treat fatal, drug-resistant pneumonia and sepsis

Pankaj Baral, assistant professor of biology, and Prabhu Raj Joshi, doctoral student in microbiology, are studying how nervous and immune system crosstalk, or bilateral signaling, impacts the body's ability to fight pneumonia caused by the Gram-negative bacteria known as carbapenem-resistant Klebsiella pneumoniae, or CRKP.
Thu, 08/29/2024

Farrell awarded patent for kifunensine analogs

Kifunensine analogs are inhibitors of mannosidase enzymes.
Wed, 07/31/2024

Former CBID pilot project leader Ackley receives new award

Former CBID pilot project leader Brian Ackley, Professor of Molecular Biosciences, receives new award from University of Kansas Medical Center Research Institute.
Mon, 07/08/2024

Baral Granted $1.87 Million by NIH to explore cell interactions that fight inflammatory disease (Opens in new window)

Pankaj Baral, Kansas State University assistant professor and CBID Pilot Project leader, has been awarded a Maximizing Investigators' Research Award, or MIRA, by the National Institute of General Medical Sciences. This early stage investigator grant will fund his study of how immune cells and sensory neurons affect tissue inflammation...

Wed, 06/05/2024

5 CBID participants earn promotion and tenure

Congratulations to five CBID faculty who have earned promotion and tenure this spring. ...

Thu, 05/09/2024

KU announces 2024 Undergraduate Research Mentor Awards

The Center for Undergraduate Research has announced the winners of two annual awards recognizing undergraduate research mentors who make a difference in the lives of their students at KU. Cindy Berrie, professor in chemistry, and Laura Kirk, associate teaching professor in theatre and film, are the 2024 honorees.
Fri, 05/03/2024

Ferreira Awarded New Faculty Research Development Award

Rosana Ferreira, CBID Research Project leader, has been awarded a New Faculty Research Development Award for her project titled "Bacterial Interactions and Their Role in the Skin Microbiome Composition." This one year award provides $20,000 to support research development of her project. ...

Fri, 04/26/2024

Teruna Siahaan Awarded An NIH R01

Thu, 04/25/2024

Study reports new compound halting replication of COVID by targeting ‘Mac-1’ protein in cell models

Research from the University of Kansas shows for the first time SARS-CoV-2, the virus responsible for COVID-19, can be inhibited from replicating in living cell cultures using a compound that targets “Mac-1,” a protein key to defending SARS-CoV-2 against the human immune response.
Thu, 03/21/2024

Orozco, CBID Research Project Leader, Finds Gene that Enhances Anti-Viral Immunity (Opens in new window)

Robin Orozco, an assistant professor of Molecular Biosciences at the University of Kansas, has unveiled new research that explores how a common mutation in the human population changes immune response during a virus infection. Dr. Orozco recently published these findings in PLoS Pathogens and provided foundational building blocks for researchers...

Thu, 02/29/2024

Siahaan and Fehr recognized as 2023 KU innovators (Opens in new window)

KU and its medical center are filled with great innovators striving to find creative solutions for the problems facing our world. Today, the KU Center for Technology Commercialization wants to thank all members of KU's research community for their creativity and ingenuity. We also wish to show specific appreciation to...

Mon, 02/26/2024

Hefty elected to NAIPI National Committee (Opens in new window)

Congratulations to Dr. Scott Hefty, CBID Program Director, for being elected to the National Committee of the National Association of IDeA Principal Investigators (NAIPI). The mission of NAIPI is to provide leadership and communication for the development, promotion and improvement of biomedical research through the INBRE, COBRE, and CTR IDeA...

Mon, 02/26/2024

Hefty elected to NAIPI National Committee

Congratulations to Dr. Scott Hefty, CBID Program Director, for being elected to the National Committee of the National Association of IDeA Principal Investigators (NAIPI). NAIPI aims to protect and promote the IDeA programs. It fosters interactions, promotes resource sharing, enhances the national visibility of the INBREs, CoBREs, and CTRs, develops...

Media Contacts

Shelley Sandberg

Program Manager

785-864-6115